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Acute and chronic hypoxia 
differentially predispose lungs for 
metastases
Moritz Reiterer1,2, Renato Colaço2, Pardis emrouznejad2, Anders Jensen2, Helene Rundqvist  3, 
Randall S. Johnson  2,3 & Cristina Branco  1,2
Oscillations in oxygen levels affect malignant cell growth, survival, and metastasis, but also somatic 
cell behaviour. In this work, we studied the effect of the differential expression of the two primary 
hypoxia inducible transcription factor isoforms, HIF-1α and HIF-2α, and pulmonary hypoxia to 
investigate how the hypoxia response of the vascular endothelium remodels the lung pre-metastatic 
niche. Molecular responses to acute versus chronic tissue hypoxia have been proposed to involve 
dynamic HIF stabilization, but the downstream consequences and the extent to which differential 
lengths of exposure to hypoxia can affect HIF-isoform activation and secondary organ pre-disposition 
for metastasis is unknown. We used primary pulmonary endothelial cells and mouse models with 
pulmonary endothelium-specific deletion of HIF-1α or HIF-2α, to characterise their roles in vascular 
integrity, inflammation and metastatic take after acute and chronic hypoxia. We found that acute 
hypoxic response results in increased lung metastatic tumours, caused by HIF-1α-dependent 
endothelial cell death and increased microvascular permeability, in turn facilitating extravasation. This 
is potentiated by the recruitment and retention of specific myeloid cells that further support a pro-
metastatic environment. We also found that chronic hypoxia delays tumour growth to levels similar 
to those seen in normoxia, and in a HIF-2α-specific fashion, correlating with increased endothelial cell 
viability and vascular integrity. Deletion of endothelial HIF-2α rendered the lung environment more 
vulnerable to tumour cell seeding and growth. These results demonstrate that the nature of the hypoxic 
challenge strongly influences the nature of the endothelial cell response, and affects critical parameters 
of the pulmonary microenvironment, significantly impacting metastatic burden. Additionally, this work 
establishes endothelial cells as important players in lung remodelling and metastatic progression.
Extravasation efficiency is a critical rate-limiting step of the metastatic cascade1 and vascular endothelial cells 
(EC) constitute the main barrier, affecting both blood flow and cell penetration to surrounding tissues1–3. 
Microvessels are typically the site of arrest of circulating tumour cells (CTC), often present from the onset of 
cancer, and these micro-occlusions impair tissue perfusion and reduce oxygen availability - transiently or long 
term - leading to altered EC behaviour and microvascular integrity4,5.
The hypoxia-sensitive family of Hypoxia Inducible factors (HIF) are key regulators of EC physiology and of 
the metabolic shifts underlying their responses to oxygenation and organ demand6–9. Endothelial HIF can be 
stabilized as a result of transient ischemic events10, such as the arrest of CTC in small capillaries11 but also in 
response to cytokine and tumour-derived signals, and indirectly via pharmacological agents or radiotherapy12–14.
Our previous work has shown that deletion of endothelial HIF-1α inhibits growth of lung metastasis in spon-
taneous breast cancer, implanted mammary gland tumours, or models of experimental metastasis, whereas dele-
tion of HIF-2α increases metastatic frequency in all of these models15,16. The lungs are frequent hosts of metastatic 
tumours, and are often the first microvascular network encountered by CTC; additionally, the pulmonary vas-
culature is particularly responsive to changes in oxygenation. Most pulmonary hypoxic challenges are intermit-
tent17, and can result from a myriad of pathologies or environmental challenges18, ranging from hypertension19,20, 
smoke exposure, cardiovascular and hepatic disease21, to sleep apnoea22–24. Importantly, it has been shown that 
intermittent hypoxia can lead to the stabilization of HIF-1α and decreases in HIF-2α levels in lung tissue25,26, 
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with detrimental effects on cancer progression17,22. A number of groups have shown that each HIF isoform has 
downstream physiological consequences that are cell-type specific22,27,28, and the stabilization of either in different 
contexts can determine disease outcome.
We hypothesised that the stabilization of either of these HIF factors will have a role in modulating the lung 
microenvironment and affect its vulnerability to metastatic colonization depending on the relative abundance of 
HIF-1α and HIF-2α.
In this work, one or the other isoform of HIF transcription factors was selectively induced in the lung 
microenvironment using acute (for highest HIF-1α stabilization) and chronic (for highest HIF-2α stabilization) 
environmental hypoxia exposure. The efficiency of lung tumour seeding in the different pre-conditioning settings 
was characterized. Additionally, animals with lung endothelium-specific29 deletion of HIF isoforms were used to 
investigate which components of organ remodelling were mediated by EC-derived signals, and to establish the 
role of endothelial HIF in lung vulnerability to metastatic colonization.
The endothelial response to hypoxia is shown to remodel the lung microenvironment in a time-dependent 
manner: acute environmental hypoxia, driving stabilization of pulmonary HIF-1α results in a pro-metastatic 
environment, while chronic environmental hypoxia, and concomitantly higher levels of HIF-2α, reduces 
endothelium-mediated metastatic cell penetrance.
Results
EC response to hypoxia results in staggered and dynamic activation of HIF transcription factors. 
Primary lung EC were transferred to 1% O2 and HIF-α isoform activation was assessed over time. HIF-1α acti-
vation is seen at the shorter exposure time-points, peaking at 4 h and starting to decline after 8 h, when increased 
stabilization of HIF-2α becomes more evident (Fig. 1A), consistent with what has recently been reported for 
microvascular cells of human lung and other organs30. To investigate whether this pattern of HIF isoform expres-
sion is also seen in vivo, animals were exposed to environmental hypoxia (10% O2). After 24 h and 10d exposures, 
HIF activation was assessed in whole lung tissue by western blotting (Fig. 1B), and levels of both isoforms are 
increased in hypoxic lungs, irrespective of exposure length; however HIF-1α is preferentially activated after 24 h 
of hypoxia, and hardly detectable in lungs of mice exposed to normoxia or prolonged hypoxia; HIF-2α protein is 
seen in all time points, but highest after prolonged (10d) exposure to hypoxia (Fig. 1B). Total lung HIF signal was 
also investigated by immunofluorescence (Fig. 1C), and frozen tissue was stained for both HIF (green signal) and 
endothelial cells (Podocalyxin, red). In the panels to the right, average total HIF signal is shown for each isoform 
(grey line, left y-axis), as well as endothelial-derived HIF, quantified by co-localization of podocalyxin and HIF 
signal (green line, right y-axis). Even though HIF is expected to be stabilised in multiple cell types in response to 
hypoxia, the activation pattern of endothelial HIF follows that seen in whole lung tissue, and confirms the trend 
seen in Fig. 1B.
The time-points and activation patterns seen in vivo do not fully overlap with the ones seen ex-vivo. This is 
likely a result of the fact that atmospheric O2 levels used to trigger a hypoxic response in the lung endothelium 
are different from those necessary to trigger the same response in EC in the tissue culture environment. The 
in-vivo model was used to reflect the effect of endothelial HIF in modulating metastatic success, independently 
of tumour-derived signals. Thus, acute and chronic hypoxia were defined as the treatments yielding the highest 
activation of HIF-1α or HIF-2α, respectively, and these conditions were subsequently used to test differential 
organ susceptibility to metastatic tumour colonization, as a function of EC activation status.
Hypoxia pre-conditioning affects metastatic tumour burden in a time-dependent manner. To 
assess the effect on organ susceptibility to colonization by CTC after hypoxia, animals in each pre-treated group 
received tumour cells intravenously, as illustrated in Supplementary Fig. 1A,B. Lung tumours were counted by 
H&E staining of paraffin-embedded sections obtained 14d post injection, during which animals were maintained 
in normal room air (Supplementary Fig. 1B,C).
Mice exposed to acute hypoxia, showing the highest lung HIF-1α levels (Fig. 1B,C), had more tumours than 
the controls breathing room air, whereas mice exposed to chronic hypoxia developed lung tumours in numbers 
similar to those found in normoxic controls (Fig. 1D).
Microvascular permeability transiently increases during adaptation to hypoxia. Lung micro-
vascular permeability was quantified using intravenous administration of Evans Blue (EB) to investigate if higher 
tumour incidence is the result of improved extravasation efficiency, due to increased vascular leakage. EB leaked 
from the lung microvasculature was quantified by spectrometry of the bronchoalveolar lavage of a minimum of 5 
animals per group, collected 20 min post EB injection. An increase in permeability was seen after 24 h of hypoxia 
(Supplementary Fig. 2A) and correlates with increased number of lung tumours. When hypoxic exposure was 
prolonged to 10 days, permeability returned to the levels seen in animals maintained in room air.
Transcripts of genes that regulate vascular permeability were surveyed by qPCR from whole lung extracts. 
The inducible nitric oxide synthase (iNOS) and vascular endothelial growth factor A (VEGF) are expressed at 
the highest levels after acute hypoxia, when permeability and metastatic incidence are also increased, whereas 
levels of VE-cadherin transcript drop in acute hypoxia (Supplementary Fig. 2B). Arginase II expression, a HIF-2α 
target7, increases only after prolonged hypoxia. These differences are not statistically significant, illustrating the 
diverse contribution of different cell types to whole-lung transcript levels, likely responding in different ways to 
the same hypoxic challenge, and underscoring that only a subset will effectively contribute to the observed trends.
iNOS protein was shown to be visibly elevated by acute hypoxia in frozen lung sections (Supplementary 
Fig. 2C,D) and also in primary EC (Supplementary Fig. 2E); iNOS activity is transcriptionally regulated by 
HIF-1α, but not HIF-2α, and its accumulation corroborates HIF-1α activation and suggests increased permea-
bility as a result of subsequent NO production15.
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Figure 1. Distinct temporal patterns of activation of HIF-1 and HIF-2 primary lung endothelial cells and whole 
lung tissue, and impact on metastatic seeding. (A) Representative western blot of HIF-1α, HIF-2α and loading 
control (TBP- tata binding protein, or β-actin), from nuclear extracts of primary mouse lung EC exposed to 
a hypoxic (1% O2) or normal atmosphere (21% O2) over time. Graph below shows quantification of signal 
intensity of HIF signal for each time point, normalised to respective loading control; The signal of normoxic 
samples used for quantification, as well as additional replicates and whole membrane controls are presented in 
Supplementary Figs 7–9. (B) Whole lung HIF-1α and HIF-2α western blot (quantification underneath), from 
mice in normal atmosphere or housed in hypoxic chambers (10% O2) for a short exposure (24 h) or prolonged 
exposure (10d). HIF signal was normalized to β-actin. Data are Avg. fold change (hypoxia/normoxia) ± SD, 
n ≥ 3 per treatment; (C) Immunofluorescent detection of HIF-1α (top) and HIF-2α (bottom) signal in frozen 
lungs of mice maintained at 21% O2 (normoxia), or exposed to oxygen-deprived atmosphere (10% O2, hypoxia) 
for 24 h or 10d. Charts on the right represent the Avg. signal ± SD, obtained from a minimum of 10 evenly 
spaced lung sections from ≥ 5 mice per treatment, 5 images acquired per section; left y-axis represents total 
HIF intensity (grey line on the chart); endothelial HIF signal was calculated from co-localized signal between 
HIF and podocalyxin, and is shown on the right y-axis (green line on the chart). Significance assessed by 
student’s t-tests; *p < 0.05, ***p < 0.001 refers to comparisons between time-points; (D) Average number of 
lung tumours ± SD counted from a minimum of 20 evenly spaced paraffin sections of lungs harvested 14d 
post tumour cell injection, n ≥ 5 animals per group. Significance was assessed by students t-test with Welch’s 
correction, *p < 0.05. Illustrative H&E sections shown below, white circles highlight tumour lesions.
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To evaluate potential differences in the lung microenvironment during hypoxia, different cell populations 
were quantified by flow cytometry of lungs harvested immediately after each treatment. A significant decrease in 
the relative number of EC (CD31+CD45−) is seen after acute hypoxia (Fig. 2A). An additional group of animals 
instead received intravenous tumour cell injections after each hypoxia pre-treatment, and were subsequently 
removed from the hypoxic chambers; lungs were analysed by flow cytometry only 24 h later. The decrease in 
CD31+CD45− cells in this experimental group is strikingly exacerbated (Supplementary Fig. 3), suggestive of a 
suppression in EC proliferation, or increased cell death as part of the remodelling process31 which is only seen in 
the acute hypoxia pre-condition, but not in the chronically treated animals.
To investigate this possibility, cell death was visualised by TUNEL signal, which was increased after acute 
hypoxia. Figure 2B shows representative images of TUNEL-stained frozen sections at different magnifications, 
to illustrate changes in overall rates of cell death as well as tissue distribution of TUNEL-positive cells. Signal 
per section (percent TUNEL+ cells per field), is shown in the chart below (gray line), and EC-specific TUNEL 
(TUNEL + Podocalyxin, green line), shows that the pattern of cell death for EC is similar to that seen for whole 
lung, and correlates with the increased vascular permeability seen at this time point (Supplementary Fig. 2A).
Selective macrophage recruitment after short and prolonged hypoxia. Because myeloid cell infil-
tration is implicated in vascular remodelling and extravasation32,33, an antigen-presenting cell population was 
identified by Mac2 (Galectin-334) staining, in paraffin-embedded tissue of lungs from mice exposed to different 
treatments (Fig. 3A). Mac2-positive cells represent a heterogeneous group of myeloid cells that can perform 
multiple functions. Their density appears higher in acutely hypoxic lungs and is maintained in lungs exposed 
to chronic hypoxia (Fig. 3B, left). Association of Mac2-positive cells (green) with the endothelium (red), known 
to be a key parameter in tumour cell transendothelial migration32,35,36, is also not different between acute and 
chronic hypoxia, although in both cases it is higher than in animals maintained in normoxic room air (Fig. 3B, 
right). Finally, whole lung mRNA levels of intercellular adhesion molecule 1 (ICAM1), involved in mediating 
endothelium-macrophage adhesion37,38, are also higher in both hypoxia treatments relative to levels seen in lungs 
from control animals (Fig. 3C). These data suggest an overall increase in myeloid cell infiltration in hypoxic lungs, 
irrespective of length of hypoxia exposure, which does not correlate with the different metastatic burden seen in 
each condition.
This result was validated by flow cytometry, where CD45+CD11b+ cells were gated directly from the viable 
cell population, after hypoxia pre-treatment (Fig. 3D, top row), and a similar result was obtained, showing an 
increased rate of myeloid cell infiltration in response to both acute and chronic hypoxia. Intriguingly, when lungs 
were harvested 24 h after tumour cell injection, there was a striking increase in CD45+CD11b+ cells in the lungs 
of mice pre-exposed to acute hypoxia (Fig. 3D, bottom row). This suggested the presence of a recruitment signal 
stimulated by acute hypoxia, but that is activated or increased in the presence of a second insult, in this case, 
tumour cells.
CCL2 is a known mediator of EC interaction with macrophages, and essential for metastatic success in breast 
cancer35,39–41, and we investigated whether this was the signal promoting the increase in general myeloid cell 
population (CD45+CD11+ cells) in that group of animals. CCL2 mRNA levels were dramatically elevated in 
lungs of animals exposed to acute hypoxia, but not after prolonged hypoxia (Fig. 3E); this increased expression is 
concomitant with the transient increase in myeloid cell retention seen in Fig. 3D (bottom panel).
CCL2 levels were also seen to increase in primary lung EC-conditioned medium (Fig. 3F), as were levels of 
mCSF1 (also a mediator of EC-myeloid cell communication). Levels of EC-secreted CCL2 were further verified by 
ELISA in the same conditioned media samples (Fig. 3G). These results suggest that CCL2, produced by EC after 
acute hypoxia, potentiates lung vulnerability to CTC by remodelling the pulmonary tissue microenvironment.
To confirm this, we assessed the infiltration of CCR2+ macrophages into the lung by flow cytometry, which 
is seen to increase only in animals exposed to acute hypoxia (Fig. 3H). These data show that the myeloid cells 
identified as Mac2+ (Fig. 3A) or CD45+CD11b+ (Fig. 3D), represent a heterogeneous myeloid cell population, 
and that EC-derived CCL2 (a HIF-1α transcriptional target42,43) selects for the arrest of pro-metastatic myeloid 
cells (CCR2+)39 in the lung during acute hypoxia. Mice were given tumour cell injections while still in the hypoxic 
chamber, but were returned to room air for either 24 h (to evaluate changes during early extravasation events) or 
14d (to assess overt metastasis). They were returned to normoxia to circumvent the effect that continuous hypoxia 
would have in the movement of tumour cells themselves, or in tumour progression. This allowed observations to 
be attributed only to the effect of pre-existing hypoxic microenvironment. In either acute or prolonged hypoxia, 
the removal of the animals from the chamber post-tumour cell injection resulted in a period of reoxygenation, 
which will likely affect the vasculature. Nevertheless, and irrespective of the oxidative consequences derived from 
the experimental approach, lungs of mice exposed to prolonged hypoxia did not show selective retainment of 
CD45+CD11+ cells.
EC viability and pulmonary vascular permeability are mediated by HIF. EC viability in hypoxia is 
compromised relative to viability at normoxia, but Cre-mediated deletion of HIF-1α appears to protect cells from 
hypoxia-induced death, especially in the acute phase (4 h at 1% O2), as seen in Supplementary Fig. 2F. As previ-
ously shown15, cells lacking HIF-1α fail to accumulate iNOS mRNA after 4 h (Fig. 4A), although this is not seen 
after 24 h of hypoxia, suggesting an alternative and HIF-1α-independent iNOS activation. An analogous trend, 
albeit less marked, is seen for BNIP3 transcript in HIF-1αCre+ cells. iNOS and BNIP3 are known HIF-1α tran-
scriptional targets44, and interestingly, both are increased in cells lacking HIF-2α after acute, but not prolonged, 
hypoxia.
BNIP3 drives a unique pro-apoptotic pathway, which bypasses the canonical leakage of mitochondrial 
cytochrome c45, and has been proposed to be activated downstream of NO46,47. To better understand how hypoxia/
HIF-1α-induced NO accumulation might affect apoptosis, EC were harvested from animals with a conditionally 
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Figure 2. Endothelial cell population decreases with acute hypoxia exposure (A) Representative flow cytometry 
plots sorted for EC marker CD31+CD45− viable cells are shown for each treatment and control; lung tissue was 
sorted immediately after hypoxia treatment (no tumour injection); graph below represents average % of viable 
EC (CD31+CD45−); (B) Representative images of TUNEL staining of frozen lung sections from mice exposed 
to normoxia and hypoxia, and counter-stained with vasculature marker Podocalyxin; scale bar = 50 μm; 
Quantification of total TUNEL staining in each group (grey line) and EC + TUNEL (green line) obtained by co-
localization of TUNEL and Podocalyxin signals; values represent Avg. ± SE number of TUNEL-positive cells; 
images were obtained from randomly selected individual sections of a minimum of 4 mice in each treatment, at 
least 8 sections per animal, 3 images per section. *p < 0.05, **p < 0.005, ***p < 0.001, by Student’s t-test with 
Welch’s correction.
6Scientific RepoRts | (2019) 9:10246 | https://doi.org/10.1038/s41598-019-46763-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
fo
ld
 c
ha
ng
e
(tr
ea
tm
en
t/n
or
m
ox
ia
)
0.0
0.5
1.0
1.5
2.0
0.0
0.5
1.0
1.5
2.0
2.5
fo
ld
 c
ha
ng
e
(tr
ea
tm
en
t/n
or
m
ox
ia
)
mCSF
CCL2
21% O2
1% O2
mCSF
CCL2
mCSF
CCL2
**
**
ctrl
ctrl
21% O2 1 % O2
21% O2 1 % O2
0
1
2
3
fo
ld
 c
ha
ng
e
(tr
ea
tm
en
t/n
or
m
ox
ia
)
CCL2  (ELISA)
21% O2 10% O2 24h 10% O2 10d
>
CD11b
>
CD
45
knalb
VTtsop
h42
0
2
4
6
8
10% O2
***
*
ns
21% O2 24h 10d 0
20
40
60
80
***
***
ns
21% O2 24h 10d
10% O2
%
 a
ss
oc
ia
tio
n 
w
ith
 E
C
0.000
0.001
0.002
0.003
0.004
0.005
***
***
ns
21% O2 24h 10d
10% O2
IC
A
M
1
re
la
tiv
e 
m
RN
A
 a
bn
da
nc
e
21% O2 10% O2 24h 10% O2 10d
Mac-2
EC
dapi
20
25
30
35
%
 C
D
45
+C
D
11
b+
/ v
ia
bl
e
**
ns*
21% O2 24h 10d
10% O2
0
20
40
60
80
 %
 C
D
45
+C
D
11
b+
/v
ia
bl
e *** ***
21% O2 24h 10d
10% O2
0
10
20
30
* ***
%
 C
C
R2
+
 m
ye
lo
id
 c
el
ls
***
0.0000
0.0001
0.0002
0.0003
0.0004
0.0005 *** ***
C
C
L2
re
la
ti
ve
 m
R
N
A
 a
b
n
d
an
ce
21% O2 24h 10d
10% O2
21% O2 1 % O2
21% O2 10 % O2 24h 10 % O2 10d
Figure 3. Inflammatory landscape during hypoxia exposure is distinct after short and long treatments and 
correlates with metastatic pre-disposition. (A) Representative IF images from paraffin-embedded lung sections 
probed for vasculature (Podocalyxin) and myeloid cells (Mac-2); scale bar = 100 μm (B) left, no. of Mac-2+ cells 
per field; right, % Mac-2+ cells associated with EC; Shown Avg ± SD, n ≥ 4 mice per treatment, 10 sections/
animal; (C) relative mRNA levels for intercellular adhesion molecule (ICAM1) in whole lung tissue (same 
animals as in A and B), shown Avg ± SD; (D) Representative flow cytometry scatter plots of CD45+CD11b+ 
cells from samples obtained immediately after each treatment (blank, no tumour cell injection, top panel) or 
24 h post tail vein injection of tumour cells (bottom panel). Animals are transferred to normal room air after 
tumour cell injection to avoid hypoxia effect on tumour cell motility; quantification is shown on the right, n ≥ 4 
mice per group; (E) CCL2 mRNA levels in whole lung; Avg. ± SD, n ≥ 4; (F) Cytokine array of normoxic and 
hypoxic primary lung EC-conditioned medium; representative blots showing CCL2 and mCSF signal (left), 
quantification by densitometry, normalized to internal array controls (light grey box) on the right; Avg. ± SD, 
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targeted NOS2 (iNOS) gene48, which was subsequently excised ex-vivo by Cre-mediated recombination. We 
found that NOS2-null EC have impaired BNIP3 accumulation in acute, but not chronic hypoxia (Fig. 4A). It is 
also seen that iNOS protein levels are lower in animals lacking pulmonary EC HIF-1α7,29, and is highest in ani-
mals lacking lung endothelial HIF-2α (Fig. 4B).
To assess endothelial integrity, EC monolayers of different genotypes were cultured on Fluoroblock inserts, 
assembled in a Boyden chamber-like setting. A FITC-labelled dextran solution was loaded in the upper chamber, 
and the fluorescence in the lower chamber, representing the amount of dextran able to cross the endothelial bar-
rier, was quantified in real time using an Omega plate reader (BMG Labtech). HIF-1α null endothelium (blue) is 
significantly less permeable than wild type (WT) (control Cre− double-floxed cells, black), whereas HIF-2α null 
(orange) monolayers exhibit much higher permeability (Fig. 4C), suggesting HIF-mediated intercellular junction 
stability. The values reflect the different arbitrary fluorescent unit ranges within each plate relative to WT controls.
Hypoxia-driven predisposition for metastasis is mediated by endothelial HIF. Animals carrying 
deletion of lung EC HIF-1α or HIF-2α were used to investigate in vivo hypoxia-induced metastasis. HIF-1αL1 
and HIF-2αL1 animals, generated with specific Cre recombinase expression in the pulmonary endothelium29, 
and Cre− controls were exposed to hypoxia treatments prior to tumour cell injections, as before. Metastatic bur-
den was again assessed 14 days post intravenous injection of tumour cells.
In normoxic conditions, deletion of HIF-1α (blue) results in fewer lung tumours, whereas deletion of HIF-2α 
(orange) leads to increased tumour burden (Fig. 5A, left). Acute hypoxia exposure does not cause increased lung 
tumour frequency in the HIF-1αL1 mice (blue symbols in left and middle panels), whereas control mice (black 
symbols) show more tumours when subjected to this same treatment (Fig. 1D). The difference in metastatic 
burden between WT and HIF-1α pulmonary EC deletion mice pre-exposed to acute hypoxia is thus significantly 
exacerbated. Interestingly, acute hypoxia does not further increase metastasis in HIF-2α pulmonary EC deletion 
animals compared to normoxic controls (orange symbols, left and middle panels), and as such there is no signif-
icant difference in tumour burden between those and WT controls. However, HIF-2αL1 animals pre-exposed to 
chronic hypoxia show more lung tumours when compared to the other genotypes in the same pre-treatment, and 
at this time-point there is no difference between the metastatic burden found in HIF-1αL1 and WT.
When assessing tumour areas within tumour-containing sections in the hypoxia treated groups (either acute 
or chronic), the differences between genotypes are subtle (Supplementary Fig. 4). However, the proportion of sec-
tions containing tumours, consistent with overall tumour burden, is lower in animals lacking endothelial HIF-1α 
in all pre-treatments, especially after acute hypoxia (Supplementary Fig. 4B). This argues for a significant role of 
this isoform in disrupting endothelial barrier function during the initial phase of the vascular hypoxia response, 
and in promoting the frequency of extravasation events, but not necessarily the proliferation of extravasated cells 
or the expansion of secondary tumours.
All genotypes have more TUNEL+ cells after acute hypoxia, and in all cases these decrease after chronic 
hypoxia exposure. Additionally, HIF-2αL1 mice have consistently higher percentages of TUNEL+ cells (Fig. 5B) 
than the other genotypes, consistent with viability pattern seen in cultured EC (Supplementary Fig. 2F). However, 
unlike what was seen in isolated EC, HIF-1αL1 lungs appear to have slightly higher rates of EC cell death than 
WT (Fig. 5B).
Co-localization of TUNEL and Podocalyxin signals is shown in Table 1. This table summarises the proportion 
of EC found within the total TUNEL+ cells, not the absolute number of TUNEL+EC. In the group treated for 
acute hypoxia (24 h), HIF-1αL1 lungs have an average 15.5% TUNEL+ EC; this is considerably lower than the 
rates of EC cell death seen in wild-type animals (27.9%). HIF2α-L1 animals show a much higher rate of EC cell 
death, with an average 49.4% of TUNEL+ EC co-staining. This discrepancy is not seen in either of the other treat-
ments, corroborating a HIF-1α-driven cell death that occurs only during an acute response to hypoxia. HIF-2αL1 
mice have constitutively higher TUNEL+ EC than other genotypes under all conditions, and thus the slightly 
lower proportion of dead EC in the 10d hypoxia group in fact represents overall more TUNEL+ EC, because there 
is higher TUNEL signal overall (approximately 2-fold higher than seen HIF-1αL1 animals, Fig. 5B).
Endothelial response to hypoxia affects the lung inflammatory milieu. Numerous studies have 
reported the role of macrophages in tumour cell extravasation32,49–51, as well as in vascular remodelling49. Thus, 
it was essential to understand if the rates of inflammation in response to acute and chronic hypoxia in mutant 
lungs were different from those seen in WT controls; this was analysed by observing the CD45+CD11b+ cell pop-
ulation. Unlike in Fig. 3D, the gate was applied after selective subtraction of other cells from the myeloid lineage 
(CD45+) to more accurately quantify macrophage infiltration52.
In WT animals, a higher number of macrophages was found in lungs after 24 h of hypoxia (Fig. 5C, grey 
panels), correlating with increased metastatic incidence (Fig. 1D). HIF-1αL1 mice (blue) showed a constitu-
tively lower proportion of these cells, whereas HIF-2αL1 (orange) have consistently higher numbers of lung 
macrophages: HIF-2αL1 animals exhibit constitutive inflammation. The proportion of CCR2+ cells within this 
macrophage population is lower in HIF-1αL1 mice exposed to acute hypoxia (24 h) (Fig. 5D), in correlation with 
the lower level of metastatic events observed in this genotype (Fig. 5A). Following chronic hypoxia, there are no 
differences in the levels of CCR2+ macrophages between genotypes, consistent with CCL2 induction forming part 
of an acute and HIF-1α-mediated response.
n = 3; (G) ELISA of CCL2 in conditioned media (same as in F); (H) %CCR2+ cells in myeloid population 
obtained by FACS of whole lung tissue after each treatment, Avg. SEM, n ≥ 6. Significance in all cases was 
assessed by students t-test with Welch’s correction, and *p < 0.05, **p < 0.005, ***p < 0.001.
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Figure 4. Hypoxia effects on iNOS and BNIP3 expression is HIF-α dependent. (A) qPCR of iNOS and BNIP3 
in primary lung EC exposed to hypoxia; samples include WT (double-floxed controls, cre-negative), HIF-1α 
Cre+, HIF-2α Cre+ and iNOS Cre+ (infected ex-vivo), and data represents average fold change ± SEM, from 
combined results from two independent experiments, 3 replicates each; statistical significance was assessed 
ANOVA; (B) Qualitative assessment of iNOS signal in frozen lung sections from mice from different genotypes 
after different time-points; scale bar = 100 μm; (C) EC permeability was measured in vitro using freshly 
prepared FITC dextran (70 kDa)-containing media over primary lung EC monolayers cultured in fluoroblock 
inserts. Each monolayer of HIF-1α null (Cre+) or HIF-2α null (Cre+) was assessed with their respective WT 
controls (double-floxed, Cre−). Measurements are arbitrary fluorescence units that represent the amount of 
FITC dextran (70 kDa) that crossed the EC monolayer over time. Three biological replicates were performed per 
genotype.
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Figure 5. Physiological pre-disposition for metastatic colonization is dependent on lung endothelium HIF-α in 
isoform- and time-dependent manner. (A) Lung tumours per mouse were counted in H&E-stained, evenly spaced 
lung sections of WT animals (combined double-flox littermates, Cre−, black symbols), and animals lacking lung 
endothelium HIF-1α (L1 Cre+, blue symbols) or HIF-2α (L1 Cre+, orange symbols); n ≥ 5 animals per group, 10 
paraffin- embedded sections per mouse, lungs harvested 14 days post tumour cell injection; (B) TUNEL staining 
of frozen sections of WT, HIF-1α L1Cre or HIF-2α L1Cre lung tissue after each hypoxia treatment (no tumour cell 
injection), bottom panel shows mean ± SEM for each genotype over time; Scale bar = 50 µm (C) Representative plots 
of interstitial macrophage population quantified by flow cytometry (after selective subtraction of non-macrophage 
CD45+ cells) in all genotypes, after each hypoxia treatment; average percent macrophages shown on the right 
(Avg ± SEM, n ≥ 5). (D) Relative proportion of CCR2+ macrophages in pre-conditioned lungs, obtained by flow 
cytometry sorting of total lung tissue from mice exposed to different hypoxia challenges and normoxic controls; WT 
animals (combined double-flox littermates, Cre−, black symbols), and animals lacking lung endothelium HIF-1α 
(L1Cre+, blue symbols) or HIF-2α (L1Cre+, orange symbols) were used; n ≥ 5; average SEM are shown, statistical 
significance was assessed by student’s t-tests, *p < 0.05, ***p < 0.001.
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Discussion
Exposure to hypoxia involves adaptive responses that evolve over time. The remodelling processes that occur 
in lungs when exposed to transient or persistent changes in oxygen availability cause changes in immediate and 
long-term organ physiology and adaptive strategies to subsequent stimuli7. These rely initially on a shift to glyco-
lytic metabolism10,53, which is mediated by HIF-1α. HIF-1α also regulates cell fate via transcriptional activation 
of apoptotic mediators including BNIP3 and p5354. The transient increase of HIF-1α seen in whole lung tissue 
following acute hypoxia correlates with increased tumour numbers, transient increases in pulmonary microvessel 
permeability and iNOS expression (Fig. 5 and Supplementary Fig. 2B–E). Deletion of HIF-1α results in decreased 
iNOS and BNIP3 transcript levels in cultured EC, less paracellular permeability (Fig. 4), and fewer apoptotic EC 
in lungs after exposure to acute hypoxia (Fig. 5). Even though HIF activation occurs in multiple cell types within 
the lung, the experiments performed using conditional deletion of HIF in pulmonary endothelium indicate a 
substantial role of these transcription factors, specifically in the microvasculature, in the metastatic process.
Lungs lacking endothelial HIF-2α, however, have more TUNEL+ EC, and higher iNOS and BNIP3 mRNA 
expression (Fig. 4A), in line with previous reports of NO-potentiation of BNIP3 signalling46. HIF-2α is an essen-
tial regulator of endothelial barrier function, as shown in brain microvascular EC exposed to chronic hypoxia55. 
Deletion of endothelial HIF-2α has also been shown to prevent recovery from kidney injury and inflammation4,56, 
and has been proposed to be a transcriptional co-activator of VE-cadherin in a hypoxia-independent fashion5. EC 
are especially vulnerable to anoikis when compared to other cell types57, and the increased cell death seen in cul-
tured pulmonary HIF-2α null EC is likely a result of deficient EC-EC cell adhesion; this hypothesis is supported 
by the higher paracellular permeability seen in these monolayers (Fig. 4C).
iNOS accumulation and subsequent NO production are critical factors in mediating endothelial permea-
bility and cell death, which can, to a large extent, explain the increased metastatic burden in conditions where 
HIF-1α activity is highest: HIF-1αL1 animals have lower levels of iNOS, as expected44, whereas those lacking lung 
endothelium HIF-2α (HIF-2L1) have much higher iNOS transcript levels. This is seen mostly at earlier hypoxia 
time-points.
In Fig. 6, we show a model to incorporate the findings shown in this study (within shaded boxes) with previ-
ously reported data: we see differential proportion of HIF isoforms in lung endothelium depending on the oxygen 
levels and duration of hypoxia. The increased permeability of lung endothelium, seen after acute hypoxia, results 
from an increase in HIF-1α-mediated cell death; WT lungs recover after prolonged hypoxia exposure, likely via 
incremental activation of HIF-2α, but in the absence of this isoform endothelial integrity is compromised and 
appears unable to recover. This suggests that EC viability58,59 is compromised in HIF-2aL1 lungs as a result of 
deficient monolayer stability (possibly disruption of adherens junctions4,5) and increased anoikis60. Consequently, 
the interrupted microvessel barrier will facilitate extravasation events and lead to the higher metastatic burden 
seen in the absence of endothelial HIF-2α.
Also illustrated in Fig. 6 is that increased HIF-1α levels in hypoxic lungs correlate with macrophage infiltra-
tion; this has been shown to promote tumour growth and metastasis22,27; our results suggest that prolonged expo-
sure to hypoxia allows vascular regeneration, in agreement with previous reports that this is a process dependent 
on HIF-2α activation4,7,28,61. We also show that the endocrine function of lung EC changes throughout the dura-
tion of the hypoxic stimulus, in turn affecting the recruitment and arrest of myeloid cells to the lung (Figs 4 and 5). 
Upon exposure to acute hypoxia, there is a striking increase in CCL2, likely downstream of HIF-1α activation42,43, 
and an effective recruitment and arrest of CCR2+ macrophages from an already exacerbated myeloid cell popu-
lation (Fig. 3). CCR2+ macrophage infiltration is not seen in HIF-1αL1 animals, and is conversely seen at much 
higher levels in HIF-2αL1 animals only after acute hypoxia; this correlates with highest CCL2 (and HIF-1α) sig-
nals (Figs 1 and 5). We anticipate that the constitutively high density of macrophages seen in the EC null HIF-2α 
mice is a result of high rates of EC death in the lungs of these animals.
Multiple factors affect extravasation and tumour cell survival post extravasation, including macrophage assis-
tance during transendothelial migration, matrix remodelling and post-extravasation vascularization of incipient 
tumour. This study demonstrates that EC mediate a tissue’s predisposition for metastatic colonization, including 
the selective recruitment of myeloid cells. This effect is seen specifically in changes in endothelial viability, integ-
rity and endocrine function, downstream of activation of specific branches in the HIF pathway. Multiple cells may 
respond to the HIF-stabilizing stimulus, also in a time-dependent manner (Fig. 1C). Our observations validate 
the contribution of the endothelium-derived HIF, both in constitutive and adaptive responses, to the metastatic 
potential of the lung. Importantly, similarly EC-dependent remodelling phenomena are likely to occur in other 
pre-metastatic organs62.
Our experimental approach used hypoxia as a driver for differential HIF-isoform stabilization, and as a model 
to understand the role of HIF in the pre-metastatic microenvironment. This study does not include the effects of 
hypoxia in other cell types within the lung, nor the systemic effects of atmospheric hypoxia in cancer progression 
Treatment
WT HIF-1αL1 HIF-2αL1
Avg co-
localization SEM
Avg co-
localization SEM
Avg co-
localization SEM
21% O2 0.311 0.0310 0.367 0.0719 0.378 0.0929
10% O2 24 h 0.279 0.0421 0.155 0.0311 0.494 0.0437
10% O2 10d 0.388 0.0373 0.446 0.0541 0.409 0.0716
Table 1. Average co-localization of TUNEL and Podocalyxin signal in frozen lung tissue following hypoxia pre-
conditioning (n ≥10).
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and dissemination. Additionally, this model does not account for the fact that HIF isoform stabilization is initi-
ated by signals other than hypoxia17,23, especially in the context of cancer63 and therapy12,64, and those limitations 
should be addressed in the future. However, with the use of lung EC-specific deletion of HIF-1α and HIF-2α, we 
have demonstrated and substantiated the non-redundancy of these transcription factors in endothelial barrier 
function, and the relevance of the endothelium in mediating pre-metastatic organ remodelling. The understand-
ing of the molecular events downstream of cell type- and organ-specific HIF-α activation has powerful implica-
tions in the ability to pre-empt distant organ vulnerability to metastatic disease, and potentiate the development 
of improved diagnostic and therapeutic approaches for aggressive cancer types.
Methods
Please refer to Supplementary file for extended methods. Animal experiments. Mice were bred 
and housed in specific pathogen-free conditions according to ethical regulations of the UK Home Office and the 
University of Cambridge. All animals are Bl57/6, whether wild type or homozygous for lox p-flanked HIF-1α or 
HIF-2α. Specific deletion of HIF-1α or HIF-2α in pulmonary EC was generated by introducing the specific pro-
moter L165 into the homozygous floxed animals (DF). Crosses were performed using DF females and DF males 
carrying one copy of L1Cre allele (heterozygous), such that only 50% of progeny would express the Cre recom-
binase, and the remaining animals would be Cre-negative, and used as WT littermate controls. Cre-mediated 
deletion of HIF-1α allele65, shown in Supplementary Fig. 5A, has been shown to be consistently above 90%, and 
that of the HIF-2α allele66 was recently shown to be 80%7. Deletion was quantified by isolation of genomic DNA 
from endothelial cells from double-floxed male mice, exposed to adenoviral Cre infection, and normalized to 
DNA sequence of wild-type genes (with no lop-P sites, in this case, VEGF), and compared to cells trated with 
Figure 6. Effect of hypoxia in HIF-α isoform activation and endothelial barrier remodeling. In this model, we 
integrate the findings of this study (in shaded enclosed boxes) with previously reported and/or hypothesised 
processes in EC stability and metastasis. Endothelial HIF-1α levels are negligible in normoxic lung environment 
(left), whereas HIF-2α is constitutively present; this is essential for vessel stability4, microvascular perfusion56 
and endothelial barrier function (as shown in15 and Fig. 4). During the initial stages of hypoxia response 
(middle panel), and as part of the vascular remodelling process23,45, HIF-1α levels increase dramatically in 
EC, largely surpassing those of HIF-2α, and predictably results in increased NO production7,15, VEGF levels, 
apoptotic and endocrine signals (Figs 3 and 4), promoting infiltration and retention of inflammatory cells 
(Figs 3 and 5), specifically pro-metastatic CCR2+ macrophages39,41 (Fig. 5). The combined effects of acute 
hypoxia result in compromised endothelial integrity and inflammation, which should facilitate extravasation, 
and promote metastasis. With prolonged exposure to hypoxia (right panel), levels of HIF-2α increase to higher 
than those of HIF-1α, reinstating the balance observed in normoxia. Increased levels of HIF-2α should restore 
adherens junctions4 and monolayer stability, and the absence of HIF-1α results in less cell death and removal 
of CCL2 recruitment signal. Deletion of endothelial HIF-2α results in compromised integrity and likely the 
microvasculature’s ability to regenerate, leading to increased metastatic incidence (Fig. 6).
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Adenovirus expressing b-galactosidase as controls for viral infection. Supplementary Fig. 5B,C show demon-
strative IF images of L1 Cre animals, and qualitative effect of EC HIF-deletion in the detection of each isoform. 
Male mice were exposed to 10% O2 for either 24 h or 10d, in chambers with controlled humidity and CO2; control 
animals were maintained in normal atmosphere.
Metastasis assay. 5 × 105 LLCGFP cells were injected intravenously in control or hypoxia pre-treated animals. 
Animals were removed from hypoxia chambers after tumour cell injection, to avoid interference of hypoxia with 
tumour cell behaviour, and evaluate exclusively the effect of pre-existing conditions. Lungs were collected either 
24 h after tumour cell injection, to assess immediate changes in lung milieu, or 14d post-injection, for long term 
changes and quantification of tumour seeding. Fresh tissue was harvested for flow cytometry, snap-frozen for 
further processing, or paraffin-embedded for histological assessment of tumour burden.
Pulmonary vascular permeability. Evans Blue (EB) dye (50 mg/Kg) was injected intravenously into control and 
hypoxia pre-conditioned animals; Bronchoalveolar lavage was collected in 1 mL of PBS 20 min later, and the 
concentration of EB leaked from the vasculature into the bronchoalveolar space was quantified against a standard 
curve at 540 nm.
Flow cytometry. Lung tissue was digested and filtered into single cell suspensions, followed by incubation with 
fluoro-conjugated antibodies. Data was acquired on Fortessa (BD Biosciences) and analysed on FlowJo (FlowJo, 
LLC). Detailed protocols and gating strategy can be found in the Supplementary Extended Methods section.
Immunofluorescence. Lung tissue was collected immediately after hypoxia treatments into OCT compound and 
promptly frozen, without perfusion or inflation, to avoid affecting the stability of the HIF-a protein signal and the 
integrity of the endothelium itself. Primary antibody incubations (HIF-1α -NB100-10567, 1:50; HIF-2α - NB100-
13268, 1:150; iNOS, SC-651; Podocalyxin (EC counterstain69), R&D Systems AF1556, 1:200) occurred O/N at 
4 °C, and fluoro-conjugated secondary antibodies (Alexa Fluor 488, Thermofisher Scientific, or Alexa Fluor 647, 
Abcam) for 1 hour at RT. Thermofisher- Click-iT® TUNEL Alexa Fluor® 488 Imaging Assay (#C10245) was 
used with slight modifications to original protocol, including additional blocking steps. In frozen tissue sec-
tions, Podocalyxin proved the most stable stain for EC; in Supplementary Fig. 5, we show vascular IF with mul-
tiple markers (Supplementary Fig. 6A), and that Podocalyxin stain overlaps with that of CD31 in these samples 
(Supplementary Fig. 6B), confirming the specificity. This was true especially when vascular stain was performed 
in combination with other primary antibodies or dyes (such as HIF-α or TUNEL). Animal tissue was analysed in 
3 images per section, ≥ 8 sections/animal, for a minimum of 5 animals per group, per treatment. Primary lung 
EC used for imaging were cultured in gelatine-coated glass slides and fixed immediately after hypoxia treatments; 
4 slide chambers per treatment, per group were used, and a minimum of 4 images/chamber were obtained for 
analyses. All images were obtained with a Leica fluorescence microscope or Leica SP5 confocal microscope using 
a 40x or 63x Oil Immersion objectives. Images were acquired through LAS (Leica) and analysed using ImageJ70.
qPCR. abundance of specific gene transcripts were performed by standard qPCR and normalised to 
β-ACTIN. Primers for iNOS, VEGF, Arginase II and β-actin were reported elsewhere15, BNIP3Fwd:GACGAA 
GTAGCTCCAAGAGTTCTCA, and BNIP3Rev: CTATTTCAGCTCTGTTGGTATCTTGTG; VE-Cadherin primers 
were obtained from Qiagen (Cat. No. QT000110467). Data are presented as average fold-change ± SD, unless otherwise 
stated. Significance was assessed by Student’s t-tests with Welch’s correction or ANOVA, as stated in each figure.
Cell culture. EC were isolated from homozygous floxed animals, and cultured as previously described15. 
Cre-Recombinase Gesicles (Clontech, cat. No. 631449) were used for ex-vivo gene deletion.
In vitro permeability assay. Endothelial integrity was measured using real-time imaging of FITC Dextran 
70 KDa that permeated through an endothelial monolayer plated onto Fluroblok inserts (light-blocking PET, 
Corning), placed in 24-well companion plates (Falcon, Cat # 353504), in Boyden chamber-like set up. Readings 
were taken every 5 minutes for 4 hours.
Western blotting. Whole protein extracts were prepared in RIPA buffer containing protease inhibitors as per 
suppliers instructions (Roche, 11697498001), and nuclear protein extracts were obtained using NE-PER nuclear 
and cytoplasmic extraction reagents (ThermoScientific, cat. No. 78833). Samples were resolved in 3–8% Tris 
Acetate SDS gels (Life Sciences, EA0375BOX) and transferred to PVDF. Primary antibodies were used at 1:1,000 
(HIF-1α, NB-100-049, iNOS, SC-651) or 1:500 dilutions (HIF-2α, R&D AF2997), and detected following incu-
bation with HRP-conjugated secondary antibodies and ECLPlus chemiluminescence (Amersham). Image capture 
and quantification were performed using FusionFX (Vilber) using default exposure for optimal signal detection, 
and statistical analysis in all cases was done using unpaired Student’s t-test with Welch’s correction after normal-
izing target band intensity to that of β-actin control in the same sample. Original full scans of gels cropped and 
used in main figures can be found in Supplementary Figs 7, 8 and 9.
Statistical analyses. were performed using Prism 7 software, and statistical tests used are referred to in figure 
legends and supplementary materials.
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Data Availability
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